Genome-Wide Mendelian Randomization Study Reveals Druggable Genes for Cerebral Small Vessel Disease.
Xin-Zhuang YangMei-Ying HuangFei HanJun NiLi-Xin ZhouMing YaoDing-Ding ZhangYi-Cheng ZhuPublished in: Stroke (2024)
This study provides genetic evidence supporting the potential therapeutic benefits of targeting druggable genes for treating CSVD, which will be useful for prioritizing CSVD drug development.